Medicines, Poisons and Therapeutic Goods Regulation 2026
50Information requirements for prescriptions
Start here
Get a plain-English read of 50
Turn the raw legal text into a practical explanation grounded in Medicines, Poisons and Therapeutic Goods Regulation 2026.
50 Information requirements for prescriptions
50 Information requirements for prescriptions
(1) A prescription for a Schedule 4 or 8 substance must specify the following—
(a) the date on which the prescription is issued,
(b) the patient’s name, date of birth and street address,
(c) the name of the substance,
(d) the strength and dosage form of the substance,
(e) adequate directions for the administration of the substance, including, if not readily apparent, the route for administration,
(f) the quantity of the substance to be supplied,
(g) the number of times an amount of the substance may be supplied on the prescription, if applicable,
(h) the name and designation of the person who issued the prescription, and
(i) the name, street address and telephone number of—
(i) if the prescription is issued at a public health entity or private health facility—the public health entity or private health facility, or
(ii) otherwise—the person’s principal place of practice.
(2) A prescription for a Schedule 4D substance that is an anabolic-androgenic steroidal substance or a Schedule 8 substance must also specify the intervals at which an amount of the substance may be supplied on the prescription.
(3) The quantity in subsection (1)(f) must be expressed in words and numbers if the substance is a Schedule 8 substance.
(4) Subsection (3) does not apply to a conformant electronic prescription.